|
1.
|
U LaufsA UrhausenN WernerRunning exercise
of different duration and intensity: effect on endothelial
progenitor cells in healthy subjectsEur J Cardiovasc Prev
Rehabil12407414200510.1097/01.hjr.0000174823.87269.2e16079651
|
|
2.
|
JM HillG ZalosJP HalcoxCirculating
endothelial progenitor cells, vascular function, and cardiovascular
riskN Engl J Med348593600200310.1056/NEJMoa02228712584367
|
|
3.
|
GP FadiniM MiorinM FaccoCirculating
endothelial progenitor cells are reduced in peripheral vascular
complications of type 2 diabetes mellitusJ Am Coll
Cardiol4514491457200510.1016/j.jacc.2004.11.06715862417
|
|
4.
|
GP FadiniS SartoreM AlbieroNumber and
function of endothelial progenitor cells as a marker of severity
for diabetic vasculopathyArterioscler Thromb Vasc
Biol2621402146200610.1161/01.ATV.0000237750.44469.8816857948
|
|
5.
|
GP FadiniS SartoreC AgostiniA
AvogaroSignificance of endothelial progenitor cells in subjects
with diabetesDiabetes
Care3013051313200710.2337/dc06-230517277037
|
|
6.
|
MR MeyersN GokceEndothelial dyfuntion in
obesity: etiological role in atherosclerosisCurr Opin Endocrinol
Diabetes Obes14365369200710.1097/MED.0b013e3282be90a817940464
|
|
7.
|
MK RerianiLO LermanA LermanEndothelial
function as a functional expression of cardiovascular risk
factorsBiomark Med4351360201010.2217/bmm.10.6120550469
|
|
8.
|
IM ChungYM KimMH YooImmobilization stress
induces endothelial dysfunction by oxidative stress via the
activation of the angiotensin II/its type I receptor
pathwayAtherosclerosis213109114201010.1016/j.atherosclerosis.2010.08.052
|
|
9.
|
S SitiaL TomasoniF AtzeniFrom endothelial
dysfunction to atherosclerosisAutoimmun
Rev9830834201010.1016/j.autrev.2010.07.01620678595
|
|
10.
|
S KouidhiS JarbouiR MarrakchiAdiponectin
expression and metabolic markers in obesity and type 2 diabetesJ
Endocrinol Invest34e16e23201110.1007/BF0334705620651470
|
|
11.
|
H ManggeG AlmerM
Truschnig-WildersInflammation, adiponectin, obesity and
cardiovascular riskCurr Med
Chem1745114520201010.2174/09298671079418300621062254
|
|
12.
|
JE YunH KimmJ JoSH JeeSerum leptin is
associated with metabolic syndrome in obese and nonobese Korean
populationsMetabolism59424429201010.1016/j.metabol.2009.08.01219846168
|
|
13.
|
PA HeckerKM O’SheaTF GalvaoRole of
adiponectin in the development of high fat diet-induced metabolic
abnormalities in miceHorm Metab
Res43100105201110.1055/s-0030-126989821165812
|
|
14.
|
J ChangY LiY HuangAdiponectin prevents
diabetic premature senescence of endothelial progenitor cells and
promotes endothelial repair by suppressing the p38 MAP
kinase/p16INK4A signaling
pathwayDiabetes5929492959201010.2337/db10-0582
|
|
15.
|
V LavoieAE KernaleguenG CharronFunctional
effects of adiponectin on endothelial progenitor
cellsObesity19722728201110.1038/oby.2010.18720814418
|
|
16.
|
AR MoschenA KaserB EnrichVisfatin, an
adipocytokine with proinflammatory and immunomodulating propertiesJ
Immunol17817481758200710.4049/jimmunol.178.3.174817237424
|
|
17.
|
WJ LeeCS WuH LinVisfatin-induced
expression of inflammatory mediators in human endothelial cells
through the NF-kappaB pathwayInt J
Obes33465472200910.1038/ijo.2009.2419223849
|
|
18.
|
F HuangXF XiongS YouVisfatin upregulates
MMP-2 and MMP-9 expressions in human monocytes through activating
NF-kappaBZhonghua Xin Xue Guan Bing Za Zhi384554592010(In
Chinese)
|
|
19.
|
SR KimYH BaeSK BaeVisfatin enhances ICAM-1
and VCAM-1 expression through ROS-dependent NF-kappaB activation in
endothelial cellsBiochim Biophys
Acta1783886895200810.1016/j.bbamcr.2008.01.00418241674
|
|
20.
|
YC ChangTJ ChangWJ LeeLM ChuangThe
relationship of visfatin/pre-B-cell colony-enhancing
factor/nicotinamide phosphoribosyltransferase in adipose tissue
with inflammation, insulin resistance, and plasma
lipidsMetabolism599399201010.1016/j.metabol.2009.07.011
|
|
21.
|
YS KangHK SongMH LeePlasma concentration
of visfatin is a new surrogate marker of systemic inflammation in
type 2 diabetic patientsDiabetes Res Clin
Pract89141149201010.1016/j.diabres.2010.03.02020409603
|
|
22.
|
T DogruA SonmezI TasciPlasma visfatin
levels in patients with newly diagnosed and untreated type2
diabetes mellitus and impaired glucose toleranceDiabetes Res Clin
Pract762429200710.1016/j.diabres.2006.07.03116956691
|
|
23.
|
A FukuharaM MatsudaM NishizawaVisfatin: a
protein secreted by visceral fat that mimics the effects of
insulinScience307426430200510.1126/science.109724315604363
|
|
24.
|
K TakebayashiM SuetsuguS
WakabyashiAssociation between plasma visfatin and vascular
endothelial function in patients with type 2 diabetes
mellitusMetabolism56451458200710.1016/j.metabol.2006.12.00117378999
|
|
25.
|
R AdyaBK TanJ ChenHS RandevaNuclear
factor-kappaB induction by visfatin in human vascular endothelial
cells: role in MMP-2/9 production and activationDiabetes
Care31758760200810.2337/dc07-154418184904
|
|
26.
|
J DoupisS RahangdaleC GnardellisEffects of
diabetes and obesity on vascular reactivity, inflammatory
cytokines, and growth
factorsObesity19729735201110.1038/oby.2010.19320829804
|
|
27.
|
LL YanML DaviglusK LiuMidlife body mass
index and hospitalization and mortality in older
ageJAMA295190198200610.1001/jama.295.2.19016403931
|
|
28.
|
L AkilHA AhmadRelationships between
obesity and cardiovascular diseases in four southern states and
ColoradoJ Health Care Poor Underserved22Suppl
46172201110.1353/hpu.2011.016622102306
|
|
29.
|
V DeClercqC TaylorP ZahradkaAdipose
tissue: the link between obesity and cardiovascular
diseaseCardiovasc Hematol Disord Drug
Targets8228237200810.2174/18715290878584908018781935
|
|
30.
|
M BartonObesity and aging: determinants of
endothelial cell dysfunction and atherosclerosisPflugers
Arch460825837201010.1007/s00424-010-0860-y20635093
|
|
31.
|
R KobayasiEH AkamineAP DavelOxidative
stress and inflammatory mediators contribute to endothelial
dysfunction in high-fat diet-induced obesity in miceJ
Hypertens2821112119201010.1097/HJH.0b013e32833ca68c20616756
|
|
32.
|
J KetonenJ ShiE MartonenE
MervaalaPeriadventitial adipose tissue promotes endothelial
dysfunction via oxidative stress in diet-induced obese C57Bl/6
miceCirc J7414791487201010.1253/circj.CJ-09-066120526041
|
|
33.
|
KR ShortPR BlackettAW GardnerKC
CopelandVascular health in children and adolescents: effects of
obesity and diabetesVasc Health Risk Manag5973990200919997578
|
|
34.
|
NM HeidaJP MüllerIF ChengEffects of
obesity and weight loss on the functional properties of early
outgrowth endothelial progenitor cellsJ Am Coll
Cardiol55357367201010.1016/j.jacc.2009.09.03120117442
|
|
35.
|
OJ MacEneaneyEJ KushnerGP Van
GuilderEndothelial progenitor cell number and colony-forming
capacity in overweight and obese adultsInt J Obes
(Lond)33219225200910.1038/ijo.2008.26219079361
|
|
36.
|
OJ MacEneaneyEJ KushnerCM
WestbyEndothelial progenitor cell function, apoptosis, and telomere
length in overweight/obese
humansObesity1816771682201010.1038/oby.2009.49420057362
|
|
37.
|
K ToblerA FreudenthalerSM
Baumgartner-ParzerReduction of both number and proliferative
activity of human endothelial progenitor cells in obesityInt J Obes
(Lond)34687700201010.1038/ijo.2009.28020065973
|
|
38.
|
PE WesterweelFL VisserenGR
HajerEndothelial progenitor cell levels in obese men with the
metabolic syndrome and the effect of simvastatin monotherapy vs.
simvastatin/ezetimibe combination therapyEur Heart
J2928082817200810.1093/eurheartj/ehn43118824462
|
|
39.
|
K EspositoM CiotolaMI MaiorinoCirculating
CD34+ KDR+ endothelial progenitor cells
correlate with erectile function and endothelial function in
overweight menJ Sex Med61071142009
|
|
40.
|
J MalyszkoJS MalyszkoM MysliwiecVisfatin
and endothelial function in dialyzed patientsNephrology
(Carlton)15190196201010.1111/j.1440-1797.2009.01180.x20470278
|
|
41.
|
AE SchutteHW HuismanR SchutteAdipokines
and cardiometabolic function: How are they interlinked?Regul
Pept164133138201010.1016/j.regpep.2010.06.00820615436
|
|
42.
|
AR MoschenRR GernerH TilgPre-B cell colony
enhancing factor/NAMPT/visfatin in inflammation and obesity-related
disordersCurr Pharm
Des1619131920201010.2174/13816121079120894720370672
|
|
43.
|
AR MoschenS GeigerR GernerH TilgPre-B cell
colony enhancing factor/NAMPT/visfatin and its role in
inflammation-related bone diseaseMutat
Res69095101201010.1016/j.mrfmmm.2009.06.01219583971
|
|
44.
|
S VermaMA KuliszewskiSH LiC-reactive
protein attenuates endothelial progenitor cell survival,
differentiation, and function: further evidence of a mechanistic
link between C-reactive protein and cardiovascular
diseaseCirculation10920582067200410.1161/01.CIR.0000127577.63323.24
|
|
45.
|
W SuhKL KimJH ChoiC-reactive protein
impairs angiogenic functions and decreases the secretion of
arteriogenic chemo-cytokines in human endothelial progenitor
cellsBiochem Biophys Res
Commun3216571200410.1016/j.bbrc.2004.06.107
|
|
46.
|
JL NanJJ LiJG HeC-reactive protein
decreases interleukin-8 production in human endothelial progenitor
cells by inhibition of p38 MAPK pathwayChin Med J
(Engl)12219221928200919781372
|
